Hat mitgewirkt an:
-
From PCR to NGS, new approaches and possibilities for detecting pathogens in archived biopsies
-
Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing
-
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial
-
Benchmarking whole exome sequencing in the German network for personalized medicine